186 related articles for article (PubMed ID: 12610161)
1. Chimeric and pseudotyped parvoviruses minimize the contamination of recombinant stocks with replication-competent viruses and identify a DNA sequence that restricts parvovirus H-1 in mouse cells.
Wrzesinski C; Tesfay L; Salomé N; Jauniaux JC; Rommelaere J; Cornelis J; Dinsart C
J Virol; 2003 Mar; 77(6):3851-8. PubMed ID: 12610161
[TBL] [Abstract][Full Text] [Related]
2. A novel MVMp-based vector system specifically designed to reduce the risk of replication-competent virus generation by homologous recombination.
Dupont F; Karim A; Dumon JC; Mine N; Avalosse B
Gene Ther; 2001 Jun; 8(12):921-9. PubMed ID: 11426332
[TBL] [Abstract][Full Text] [Related]
3. The infectivity and lytic activity of minute virus of mice wild-type and derived vector particles are strikingly different.
Lang SI; Boelz S; Stroh-Dege AY; Rommelaere J; Dinsart C; Cornelis JJ
J Virol; 2005 Jan; 79(1):289-98. PubMed ID: 15596824
[TBL] [Abstract][Full Text] [Related]
4. Construction and production of oncotropic vectors, derived from MVM(p), that share reduced sequence homology with helper plasmids.
Clément N; Velu T; Brandenburger A
Cancer Gene Ther; 2002 Sep; 9(9):762-70. PubMed ID: 12189526
[TBL] [Abstract][Full Text] [Related]
5. DNA sequence comparison between two tissue-specific variants of the autonomous parvovirus, minute virus of mice.
Sahli R; McMaster GK; Hirt B
Nucleic Acids Res; 1985 May; 13(10):3617-33. PubMed ID: 3855242
[TBL] [Abstract][Full Text] [Related]
6. Encapsidation of a recombinant LuIII parvovirus genome by H1 virus and the fibrotropic or lymphotropic strains of minute virus of mice.
Maxwell IH; Long CJ; Carlson JO; Rhode SL; Maxwell F
J Gen Virol; 1993 Jun; 74 ( Pt 6)():1175-9. PubMed ID: 8509766
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic murine autonomous parvovirus, a candidate vector for glioma gene therapy, is innocuous to normal and immunocompetent mouse glial cells.
Abschuetz A; Kehl T; Geibig R; Leuchs B; Rommelaere J; Régnier-Vigouroux A
Cell Tissue Res; 2006 Sep; 325(3):423-36. PubMed ID: 16699801
[TBL] [Abstract][Full Text] [Related]
8. Transformation of human fibroblasts by ionizing radiation, a chemical carcinogen, or simian virus 40 correlates with an increase in susceptibility to the autonomous parvoviruses H-1 virus and minute virus of mice.
Cornelis JJ; Becquart P; Duponchel N; Salomé N; Avalosse BL; Namba M; Rommelaere J
J Virol; 1988 May; 62(5):1679-86. PubMed ID: 2833618
[TBL] [Abstract][Full Text] [Related]
9. Partial reversion of conditional transformation correlates with a decrease in the sensitivity of rat cells to killing by the parvovirus minute virus of mice but not in their capacity for virus production: effect of a temperature-sensitive v-src oncogene.
Salome N; van Hille B; Geuskens M; Rommelaere J
J Virol; 1989 Nov; 63(11):4797-807. PubMed ID: 2507792
[TBL] [Abstract][Full Text] [Related]
10. Humoral immune responses against minute virus of mice vectors.
Lang SI; Giese NA; Rommelaere J; Dinsart C; Cornelis JJ
J Gene Med; 2006 Sep; 8(9):1141-50. PubMed ID: 16800041
[TBL] [Abstract][Full Text] [Related]
11. Genome replication and postencapsidation functions mapping to the nonstructural gene restrict the host range of a murine parvovirus in human cells.
Rubio MP; Guerra S; Almendral JM
J Virol; 2001 Dec; 75(23):11573-82. PubMed ID: 11689639
[TBL] [Abstract][Full Text] [Related]
12. The mismatched nucleotides in the 5'-terminal hairpin of minute virus of mice are required for efficient viral DNA replication.
Costello E; Sahli R; Hirt B; Beard P
J Virol; 1995 Dec; 69(12):7489-96. PubMed ID: 7494255
[TBL] [Abstract][Full Text] [Related]
13. Sensitization of transformed rat fibroblasts to killing by parvovirus minute virus of mice correlates with an increase in viral gene expression.
Cornelis JJ; Spruyt N; Spegelaere P; Guetta E; Darawshi T; Cotmore SF; Tal J; Rommelaere J
J Virol; 1988 Sep; 62(9):3438-44. PubMed ID: 3404581
[TBL] [Abstract][Full Text] [Related]
14. Translation control by protein kinase R restricts minute virus of mice infection: role in parvovirus oncolysis.
Ventoso I; Berlanga JJ; Almendral JM
J Virol; 2010 May; 84(10):5043-51. PubMed ID: 20219905
[TBL] [Abstract][Full Text] [Related]
15. Continuous production of minute virus of mice by an untransformed variant of Fisher rat fibroblast (FR3T3).
Koering CE; Geuskens M; Rommelaere J
J Gen Virol; 1996 Mar; 77 ( Pt 3)():447-52. PubMed ID: 8601780
[TBL] [Abstract][Full Text] [Related]
16. Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice.
Giese NA; Raykov Z; DeMartino L; Vecchi A; Sozzani S; Dinsart C; Cornelis JJ; Rommelaere J
Cancer Gene Ther; 2002 May; 9(5):432-42. PubMed ID: 11961666
[TBL] [Abstract][Full Text] [Related]
17. Virulent variants emerging in mice infected with the apathogenic prototype strain of the parvovirus minute virus of mice exhibit a capsid with low avidity for a primary receptor.
Rubio MP; López-Bueno A; Almendral JM
J Virol; 2005 Sep; 79(17):11280-90. PubMed ID: 16103180
[TBL] [Abstract][Full Text] [Related]
18. TLR-9 contributes to the antiviral innate immune sensing of rodent parvoviruses MVMp and H-1PV by normal human immune cells.
Raykov Z; Grekova SP; Hörlein R; Leuchs B; Giese T; Giese NA; Rommelaere J; Zawatzky R; Daeffler L
PLoS One; 2013; 8(1):e55086. PubMed ID: 23383065
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal integration and homologous gene targeting by replication-incompetent vectors based on the autonomous parvovirus minute virus of mice.
Hendrie PC; Hirata RK; Russell DW
J Virol; 2003 Dec; 77(24):13136-45. PubMed ID: 14645570
[TBL] [Abstract][Full Text] [Related]
20. Method for concentrating and purifying recombinant autonomous parvovirus vectors designed for tumour-cell-targeted gene therapy.
Avalosse B; Dupont F; Spegelaere P; Mine N; Burny A
J Virol Methods; 1996 Dec; 62(2):179-83. PubMed ID: 9002076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
